Question · asked by 1 review
Ketoconazole 400 mg vs Ketoconazole 200 mg: Oral candidiasis (present)
- Population
- Patients with cancer receiving chemotherapy and/or radiotherapy
- Intervention
- Ketoconazole 400 mg
- Comparison
- Ketoconazole 200 mg
- Outcome
- Oral candidiasis (present)
What each review found
Current versions onlyNo studies found 0 · 0%GRADE not reported 3 · 100%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Ketoconazole 400 mg vs Ketoconazole 200 mg Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane All outcomes | 1 study (Scrimgeour 1985); no patient experienced oral candidiasis, not estimable | 1 study | GRADE not reported |
Ketoconazole 400 mg vs Ketoconazole 200 mg Oral candidiasis (present) · Patients with cancer receiving chemotherapy and/or radiotherapy Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2004) · Cochrane All outcomesearlier version CD003807.PUB2, superseded | 1 study (Scrimgeour 1985); no patient experienced oral candidiasis, not estimable | 1 study | GRADE not reported |
Ketoconazole 400 mg vs Ketoconazole 200 mg Oral candidiasis (present) · Patients with cancer receiving chemotherapy and/or radiotherapy Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2002) · Cochrane All outcomesearlier version CD003807, superseded | 1 study (Scrimgeour 1985); no patient experienced oral candidiasis, not estimable | 1 study | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for preventing oral candidiasis for patients with cancer receiving treatment 2007 · Cochrane All outcomes | 2009-08 | Not listed | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.